Taken together, these findings that PARP1 can be UFMylated and that a human tumor-associated mutation in PARP1 (PARP1-F553L) compromises PARP1 UFMylation demonstrate that PARP1 UFMylation may be involved in tumorigenesis. The gene discussed is PARP1; the disease is neoplasm.